TABLE 1.
N (%) (N = 1511) | |
Demographics | |
Sex, female, | 812 (61) |
Age [mean (IQR)] | 35 (27–44) |
Reason for testing (n = 1511–122 missing = 1389) | |
Clinical indication (multiple choices possible) | 462 (33) |
Loss of weight | 193 (42) |
Night sweats | 96 (21) |
Chronic cough | 78 (17) |
Weakness | 47 (10) |
Frequent hospital admission | 32 (7) |
Low CD4 count | 18 (4) |
New WHO III or IV disease | 165 (36) |
Previous elevated VL | 794 (57) |
VL after switch to 2nd line | 50 (4) |
Other | 83 (6) |
VL result | |
Suppressed (<1000 copies/mL) | 585 (39) |
Elevated VL (≥1000 copies/mL) | 926 (61) |
Patients who receive primary care at LH and had documented results during the testing period.